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It was recognized that in human milk some amounts of lactoferrin (LF) were naturally bound to secretory 
IgA (sIgA). Since not only secretory component (SC) but also LF was released from sIgA by disulfide bond 
cleavage, it is conceivable that LF is naturally bound to IgA as well as SC. An in vitro binding test to LF 
and IgA was performed and the binding was confirmed by the use of an IgA-Sepharose 4B affinity 
column. 
Lactoferrin Secretory ZgA Secretory component ZgA affinity column 
1. INTRODUCTION 
Lactoferrin (LF) is an iron-binding glycoprotein 
[l] that is present in most of the mucous fluids 
similarly to sIgA, and is involved in the 
bacteriostatic effect of human milk on Escherichia 
coli and other bacteria [2,3]. It has also been 
shown that the bacteriostatic activity is due to the 
combined effect of LF and IgA [4,5]. However, 
the mechanism by which IgA participates in the an- 
tibacterial function of LF is not clear. 
During an attempt to purify SC and sIgA from 
human milk and to make antibodies against these 
proteins, anti-LF as well as anti-SC and anti-IgA 
antibodies were unexpectedly obtained by im- 
munization with purified sIgA of rabbits [6]. 
Since not only SC but also LF was released from 
purified sIgA by disulfide bond cleavage with 
20 mM dithiothreitol, 1 M propionic acid and 
40 mM iodoacetamide, it is conceivable that LF is 
naturally bound to IgA as well as SC. This study 
was also designed to determine whether LF could 
bind to an IgA-affinity column in vitro and possi- 
ble implications of the observed binding 
phenomenon are discussed. 
2. MATERIALS AND METHODS 
Human colostrum was obtained from the 
department of Obstetrics and Gynecology, Tokai 
University Hospital, and stored frozen at -20°C 
until use. Sera from patients with IgA myeloma, 
containing dimeric IgA, were obtained at autopsy. 
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Secretory IgA and myeloma IgA were isolated 
and purified from pooled human colostrum and 
serum by combined 50% ammonium sulfate 
precipitation, DEAE-cellulose column [stepwise 
elution, 0.01 M phosphate buffer (pH 7.2), 0.05 M 
NaCl and 0.2 M NaCI] and Sephacryl S-200 gel 
filtration (Pharmacia, Uppsala). Purity was con- 
firmed by Ouchterlony double gel immunodiffu- 
sion and immunoelectrophoresis using antibodies 
to whole human serum (Medical Biological 
Laboratory, Nagoya), anti-LF (Dako, Kyowa 
Medex, Tokyo) and anti-IgA (Medical Biological 
Laboratory, Nagoya). 
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Fractions of milk sIgA and myeloma IgA eluted 
by 0.05 M NaCl on a DEAE-cellulose column 
were gel filtered on Sephacryl S-200 to obtain IgA 
of homogeneous molecular mass and to remove 
free LF. The purity of sIgA was examined by 7% 
PAGE and immunoelectrophoresis. Antibodies 
against the sIgA were prepared in rabbits by sub- 
cutaneous injections of the purified sIgA prepara- 
tion in Freund’s complete adjuvant (Difco, MI) 
every 2 weeks (5 injections in total), each injection 
containing 0.25 mg sIgA. 
IgA affinity columns were prepared as follows. 
Myeloma IgA and serum IgA eluted from DEAE- 
cellulose were coupled to AH-Sepharose 4B (Phar- 
macia) by means of l-ethyl-3-(3_dimethylamino- 
propyl)carbodiimide . HCl. One hundred mg of 
dimeric IgA and monomeric IgA each were co- 
The fraction containing SC and LF was isolated 
valently bound to 12 g AH-Sepharose 4B. 
from human colostrum by combined gel filtration 
and DEAE-cellulose chromatography as in [7]. 
Binding experiments of LF to the IgA affinity 
column were performed as in [8]. Briefly, a crude 
LF fraction of human milk was first dialysed at 
4°C against phosphate-buffered saline (pH 7.2), 
containing 5 mM each of EDTA and 
iodoacetamide, and 1% sodium azide. They were 
then passed through the IgA-Sepharose4B column 
equilibrated with the same buffer at room 
temperature. Non-bound proteins were first 
washed off from this column with the same buffer. 
A further wash of loosely bound proteins was per- 
formed by the addition of 0.5 M NaCl in the same 
buffer. Finally, bound proteins were eluted with 
the same buffer containing 1.5 M ammonium thio- 
cyanate, 5 mM EDTA and 5 mM iodoacetamide. 
Eluted proteins were estimated from the absor- 
bance at 280 nm, dialysed against ion-exchanged 
water and concentrated by lyophilization. Aliquots 
of eluted fractions .were determined by the 
Ouchterlony double immunodiffusion method 
against anti-LF antibody. 
The molecular mass of each fraction was 
estimated by 0.1% SDS-7070 PAGE [9, lo] and the 
amount in each fraction quantitated by single 
radial immunodiffusion (SRID) using anti-LF 
antibody. 
3. RESULTS AND DISCUSSION 
The elution patterns of colostrum sIgA on 
DEAE-cellulose are illustrated in fig.1. All 3 
peaks contained immunologically identified sIgA, 
but peaks 2 and 3 contained several other proteins. 
Peak 1 was used for immunization to raise anti- 
sIgA. antibodies. Purified sIgA separated by 
Sephacryl S-200 from peak 1 was also used for 
immunization. 
The first question was whether the free LF was 
contaminated in the purified sIgA fractions used 
for immunization. Since the M, of free LF is 
75 000-95 000 [ 11,121, it was easily separated from 
sIgA on Sephacryl S-200. In addition, a single 
The antisera obtained revealed 3 precipitation 
lines against human milk. These correspond to 
band is obtained by the application of the purified 
those revealed by IgA, SC and LF by using specific 
antibody as shown in fig.2. 
sIgA by Sephacryl S-200 on 7% PAGE (fig.3). 
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Fig.1. Elution patterns of colostrum sIgA on 
DEAE-cellulose column; all 3 peaks were 
immunologically s&A, but peaks 2 and 3 contained 
additional proteins. Peak 1 was used for immunization 
to raise anti-sIgA antibodies. 
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Fig.2. Immunoelectrophoresis pattern of serum from 
rabbit immunized with purified @A. Relative mobility 
of proteins was estimated by NHS (normal human 
serum) and anti-NHS (a-NHS). The anti-sIgA antibody 
(a-sIgA) in this study was examined on human milk. 
Three precipitation lines were observed, two of which 
fused to anti-LF (a-LF) and anti-SC (a-SC). 
However, LF is immunologically detected in these 
purified sIgA samples by the Ouchterlony double 
immunodiffusion method. It indicates that no free 
LF is present in the sIgA used for immunization, 
but bound LF might be detected. 
An experiment was performed to establish 
whether LF or other proteins were separated after 
reduction and alkylation of the purified sIgA on 
Sephacryl S-200 with 20 mM dithiothreitol, 1 M 
propionic acid and 40 mM iodoacetamide. The gel 
filtration patterns of the treated sIgA on Sephacryl 
S-200 are illustrated in fig.4; IgA, LF, SC and J 
chain were detected by using specific antibodies by 
the Ouchterlony double gel diffusion method. 
From these results, we speculate that a part of 
LF might be naturally bound to milk sIgA, pro- 
bably through disulfide bonds similarly to SC 
binding to J chain-linked dimeric IgA 1131. 
Experiments to determine whether LF bound to 
IgA in vitro were then performed using a dimeric 
myeloma IgA affinity column. The LF bound to 
dimeric IgA in the column was eluted by the cor- 
responding buffer. LF was not observed to bind to 
the column, the fraction loosely bound to dimeric 
IgA being eluted by 0.5 M NaCl and the tightly 
Fig.3. Profile of the repurified sIgA by Sephacryl S-200 
gel filtration examined in 7% PAGE. A single band is
obtained (track 2), showing no other contaminating 
proteins; NHS in track 1. 
bound fraction eluted by 1.5 M NI-L&CN as shown 
by Ouchterlony double gel diffusion against 
monospecific anti-LF antibody (fig.5). 
The molecular mass of the eluted LF was 
estimated in 0.1% SDS-79’0 PAGE to be approx. 
85 kDa (fig.6). An M, of approx. 68000, which 
corresponds to SC, was also observed. The LF 
binding to monomeric IgA was also examined 
using a monomeric IgA affinity column. The bind- 
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Fig.4. Gel filtration profile of the reduced and alkylated 
sIgA on Sephacryl S-200. Eluted fractions were 
estimated from the absorbance at 280 nm. IgA, LF, SC 
and J chain were detected by using relevant antibody by 
the Ouchterlony double gel diffusion method as 
illustrated. sIgA, 152 mg; DTT, 20 mM; propionic acid, 
1 M; iodoacetic acid, 40 mM. Sephacryl S-200, 2.5 x 
91 cm; eluant, 20 mM DTT containing 0.1 M Tris 
buffer (pH 8.0). 
ing to monomeric IgA or sIgA was also observed. 
Only a trace amount of LF bound to Sepharose 4B 
not coupled to dimeric IgA or monomeric IgA was 
observed. 
The binding of albumin [13,14] and 
cur-antitrypsin [15] to IgA has been reported. It 
could be that their bioavailability to target organs 
or microbes might be more effective in a com- 
plexed form, however there is as yet no direct pro- 
of of this. Also, in the case of LF, antibacterial 
activities have been reported to be enhanced when 
coexisting with IgA molecules [5]. Whether these 
binding properties of LF to IgA have any connec- 
tion with its physiological function is a matter for 
further investigation. 
Authors in [la] reported a purification method 
Fig.5. The LF bound to the IgA affinity column was 
eluted by corresponding buffers and examined by 
Ouchterlony double gel diffusion. LF was not observed 
to bind to the column (l), 0.5 M NaCl eluted loosely 
bound fraction (2) and 1.5 M NI-L+SCN eluted tightly 
bound fraction as shown by the precipitation line against 
anti-LF (A). Small amounts of SC were observed against 
anti-SC (B) but no binding of ant&r-antichymotrypsin 
was observed in the eluate (C). 
for free LF using a copper-chelate gel, since the LF 
is able to bind copper as well as iron. In that 
system an admixture of sIgA in the free LF frac- 
tion was also noted; one may speculate that the 
binding of sIgA to the copper-chelate gel could 
have occurred through the LF which was attached 
to the sIgA molecules. 
It was demonstrated [14] that LF tended to form 
associations with acidic proteins such as albumin, 
casein and lactoalbumin. However, the binding 
was dissociated by the sucrose density gradient 
technique. 
The experiments described here revealed that LF 
and SC were separated from sIgA by reduction 
with 20 mM dithiothreitol and 1 M propionic acid. 
This indicates that the binding of LF to IgA might 
have occurred through formation of disulfide 
bonds. However, in an in vitro binding experiment 
with a myeloma IgA affinity column, the binding 
of LF to IgA was dissociated with increasing 
molarity of salt, and thus the ionic binding is also 
involved in both bindings. 
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Fig.6. Estimation of molecular mass of bound LF to IgA 
affinity column. The loosely bound and tightly bound 
LF were estimated in 0.1% SDS-7% PAGE. Molecular 
masses of approx. 85 kDa and 68 kDa were revealed on 
Coomassie brilliant blue staining of the PAGE. 1, 
human milk; 2, eluted LF fraction; 3, loosely bound LF 
and 4, tightly bound LF. K, kDa. 
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